Spyre Therapeutics, Inc. (SYRE)

68.99 +4.98 (+7.78%) USD  |  NASDAQ  |  Apr 15, 16:00
69.32 +0.33 (+0.48%) After-Hours: 06:06
More

Spyre Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Tyra Biosciences, Inc. Upgrade
Savara, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade